The astroglial protein S100B and visually evoked event-related potentials before and after antidepressant treatment

RationaleS100B is an astrocytic, calcium-binding protein which in nanomolar concentrations has neuroprotective and regenerating effects on neurons and glial cells. Increased levels have been shown to be positively correlated with therapeutic response in major depression. Event-related potentials (ERP) have been reported to be impaired in depressed patients.ObjectivesThe aim of our study was to assess the relationship between S100B and visually evoked ERP in depression.MethodsERP and S100B serum concentration were studied in 18 patients with major depression, before and after 4 weeks of antidepressant treatment.ResultsThe S100B concentration in patients was increased at intake and after 4 weeks of treatment compared to healthy controls. Initially increased P3-latency normalized and P2-latency significantly decreased after 4 weeks of treatment, although only in patients with clearly elevated initial S100B levels (mean plus 2 SD of the healthy controls).ConclusionThe neuroregenerative activity of moderately increased S100B levels in major depression might be a factor contributing to a decrease of prolonged ERP parameters in major depression during antidepressant treatment.

[1]  J E Christie,et al.  Changes in Auditory P3 Event-related Potential in Schizophrenia and Depression , 1987, British Journal of Psychiatry.

[2]  L. Kaufman,et al.  The hippocampal formation as a source of the slow endogenous potentials. , 1983, Electroencephalography and clinical neurophysiology.

[3]  M. Wiesmann,et al.  S100B and response to treatment in major depression: a pilot study , 2003, European Neuropsychopharmacology.

[4]  W. Burke,et al.  Amplitude/intensity functions of auditory event-related potentials predict responsiveness to bupropion in major depressive disorder. , 1995, Psychopharmacology bulletin.

[5]  W. Ritter,et al.  The scalp topography of potentials in auditory and visual discrimination tasks. , 1977, Electroencephalography and clinical neurophysiology.

[6]  R. Ihl,et al.  Event-related potentials and psychopharmacology. Cholinergic modulation of P300. , 1994, Pharmacopsychiatry.

[7]  O. P. Tandon,et al.  A study of P300-event related evoked potential in the patients of major depression. , 1999, Indian journal of physiology and pharmacology.

[8]  M. Wiesmann,et al.  Target evaluation processing and serum levels of nerve tissue protein S100B in patients with remitted major depression , 2004, Neuroscience Letters.

[9]  D. Souza,et al.  Elevated serum S100B protein in drug-free bipolar patients during first manic episode: a pilot study , 2002, European Neuropsychopharmacology.

[10]  V. Arolt,et al.  S100B Serum Levels and Long-Term Improvement of Negative Symptoms in Patients with Schizophrenia , 2004, Neuropsychopharmacology.

[11]  J. Rohrbaugh,et al.  Endogenous potentials generated in the human hippocampal formation and amygdala by infrequent events. , 1980, Science.

[12]  D. Souza,et al.  Increased serum S100B protein in schizophrenia: a study in medication-free patients. , 2001, Journal of psychiatric research.

[13]  M. Hamilton,et al.  Development of a rating scale for primary depressive illness. , 1967, The British journal of social and clinical psychology.

[14]  B N Gangadhar,et al.  P300 amplitude in non-bipolar, melancholic depression. , 1993, Journal of affective disorders.

[15]  N. Bathien,et al.  Visual cognitive dysfunction in depression: an event-related potential study. , 1998, Electroencephalography and clinical neurophysiology.

[16]  Á. Pascual-Leone,et al.  Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression , 1996, The Lancet.

[17]  David Friedman,et al.  Event-related potentials in depression: Influence of task, stimulus hemifield and clinical features on P3 latency , 1991, Biological Psychiatry.

[18]  M. Wiesmann,et al.  S-100B is increased in melancholic but not in non-melancholic major depression. , 2001, Journal of affective disorders.

[19]  C. Yingling,et al.  A subcortical correlate of P300 in man. , 1984, Electroencephalography and clinical neurophysiology.

[20]  S. Evers,et al.  Dynamic Changes of Cognitive Habituation and Serotonin Metabolism During the Migraine Interval , 1999, Cephalalgia : an international journal of headache.

[21]  Stefan Evers,et al.  The impact of transcranial magnetic stimulation on cognitive processing: an event-related potential study , 2001, Neuroreport.

[22]  C. Nelson,et al.  P300 brain activity in seizure patients preceding temporal lobectomy. , 1991, Archives of neurology.

[23]  H. Grabe,et al.  Neurotrophic Factor S100beta in Major Depression , 2001, Neuropsychobiology.

[24]  W. Drevets,et al.  The cellular neurobiology of depression , 2001, Nature Medicine.

[25]  M. Wiesmann,et al.  Increased S100B blood levels in unmedicated and treated schizophrenic patients are correlated with negative symptomatology , 2001, Molecular Psychiatry.

[26]  R. Donato,et al.  S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. , 2001, The international journal of biochemistry & cell biology.

[27]  V. Arolt,et al.  S100B in brain damage and neurodegeneration , 2003, Microscopy research and technique.

[28]  U Hegerl,et al.  Comparison between the analysis of the loudness dependency of the auditory N1/P2 component with LORETA and dipole source analysis in the prediction of treatment response to the selective serotonin reuptake inhibitor citalopram in major depression , 2002, Clinical Neurophysiology.

[29]  S. Yamawaki,et al.  Changes in auditory P300 in patients with major depression and silent cerebral infarction. , 1997, Journal of affective disorders.

[30]  U Hegerl,et al.  Event-related potentials: Do they reflect central serotonergic neurotransmission and do they predict clinical response to serotonin agonists? , 2001 .

[31]  M. Maes,et al.  Auditory event related potentials in major depression: prolonged P300 latency and increased P200 amplitude. , 1998, Journal of affective disorders.

[32]  M. Schroeter,et al.  S100B is increased in mood disorders and may be reduced by antidepressive treatment , 2002, Neuroreport.